Cargando…
Epigenomic and Metabolomic Integration Reveals Dynamic Metabolic Regulation in Bladder Cancer
SIMPLE SUMMARY: Current diagnostic and follow-up methods for the clinical management of bladder cancer (BC) have limitations, and there is an urgent unmet need for non-invasive biomarkers for this highly prevalent disease. Furthermore, personalized treatments for patients could improve their quality...
Autores principales: | Loras, Alba, Segovia, Cristina, Ruiz-Cerdá, José Luis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8198168/ https://www.ncbi.nlm.nih.gov/pubmed/34072826 http://dx.doi.org/10.3390/cancers13112719 |
Ejemplares similares
-
Integrative Metabolomic and Transcriptomic Analysis for the Study of Bladder Cancer
por: Loras, Alba, et al.
Publicado: (2019) -
Urinary Metabolic Signatures Detect Recurrences in Non-Muscle Invasive Bladder Cancer
por: Loras, Alba, et al.
Publicado: (2019) -
Bladder cancer recurrence surveillance by urine metabolomics analysis
por: Loras, A., et al.
Publicado: (2018) -
New bladder cancer non-invasive surveillance method based on voltammetric electronic tongue measurement of urine
por: Monreal-Trigo, Javier, et al.
Publicado: (2022) -
Spatiotemporal clustering of the epigenome reveals rules of dynamic gene regulation
por: Yu, Pengfei, et al.
Publicado: (2013)